Cargando…
Cardiopulmonary predictors of mortality in patients with COVID-19: What are the findings?()
BACKGROUND: Since 2019, coronavirus disease 2019 (COVID-19) has been the leading cause of mortality worldwide. AIMS: To determine independent predictors of mortality in COVID-19, and identify any associations between pulmonary disease severity and cardiac involvement. METHODS: Clinical, laboratory,...
Autores principales: | Kavosi, Hoda, Nayebi Rad, Sepehr, Atef Yekta, Reza, Tamartash, Zahra, Dini, Mahboubeh, Javadi Nejad, Zahra, Aghaghazvini, Leila, Javinani, Ali, Mohammadzadegan, Amir Mohammad, Fotook Kiaei, Seyedeh Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174274/ https://www.ncbi.nlm.nih.gov/pubmed/35752584 http://dx.doi.org/10.1016/j.acvd.2022.04.008 |
Ejemplares similares
-
The clinical course of COVID-19 in systemic sclerosis patients, report from 150 patients
por: Tamartash, Zahra, et al.
Publicado: (2021) -
Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis
por: Nayebirad, Sepehr, et al.
Publicado: (2023) -
Glomerulonephritis associated with systemic sclerosis: a case report
por: Nayebirad, Sepehr, et al.
Publicado: (2023) -
Bundle Branch Blocks and Fragmented QRS Complex in Iranian Patients with Systemic Sclerosis
por: Javinani, Ali, et al.
Publicado: (2019) -
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
por: Saleh, Mahshid, et al.
Publicado: (2022)